Alexandra Berger
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Lentivirus-mediated gene therapy for Fabry disease: 5-year End-of-Study results from the Canadian FACTs trial.
Journal: Clinical and translational medicine
Published: July 27, 2024
Engineered murine IL-21-secreting leukemia cells induce granzyme B+ T cells and CD4+CD44+CD62L- effector memory cells while suppressing regulatory T cells, leading to long-term survival.
Journal: Cancer immunology, immunotherapy : CII
Published: October 06, 2022
Hemokinin-1 as a Mediator of Arthritis-Related Pain via Direct Activation of Primary Sensory Neurons.
Journal: Frontiers in pharmacology
Published: August 13, 2020
Interleukin-15 in cancer immunotherapy: IL-15 receptor complex versus soluble IL-15 in a cancer cell-delivered murine leukemia model.
Journal: Journal for immunotherapy of cancer
Published: July 04, 2019
Functional Consequences of the Postnatal Switch From Neonatal to Mutant Adult Glycine Receptor α1 Subunits in the Shaky Mouse Model of Startle Disease.
Journal: Frontiers in molecular neuroscience
Published: February 27, 2018
Differential regulation of IgA+ B cells in vitro by stromal cells from distinctive anatomical compartments.
Journal: Journal of leukocyte biology
Published: May 08, 2017
Disruption of a Structurally Important Extracellular Element in the Glycine Receptor Leads to Decreased Synaptic Integration and Signaling Resulting in Severe Startle Disease.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: January 02, 2017
Hemokinin-1 mediates anxiolytic and anti-depressant-like actions in mice.
Journal: Brain, behavior, and immunity
Published: June 13, 2016
Tumor-secreted products repress B-cell lymphopoiesis in a murine model of breast cancer.
Journal: European journal of immunology
Published: June 03, 2016
Last Updated: 09/26/2026